Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia-Reference-Cited by-同舟云学术

Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia

Published:2020-11 Issue: Volume:333 Page:113413
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Bartlett Mitchell J.,Flores Andrew J.,Ye Tony,Smidt Saskia I.,Dollish Hannah K.,Stancati Jennifer A.,Farrell Drew C.,Parent Kate L.,Doyle Kristian P.,Besselsen David G.,Heien Michael L.,Cowen Stephen L.,Steece-Collier Kathy,Sherman Scott J.,Falk Torsten^ORCID

Funder

Jerry T. and Glenda G. Jackson Fellowship

Evelyn F. McKnight Brain Institute

Arizona Biomedical Research Commission

National Institute of Health

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference80 articles.

1. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR;Akinfiresoye;Psychopharmacology,2013

2. Alterations of intrinsic brain connectivity patterns in depression and bipolar disorders: a critical assessment of magnetoencephalography-based evidence;Alamian;Front. Psych.,2017

3. ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons;Alonso;Learn. Mem.,2004

4. Anterograde transport of brain-derived neurotrophic factor and its role in the brain;Altar;Nature,1997

5. Ketamine for depression, 1: clinical summary of issues related to efficacy, adverse effects, and mechanism of action;Andrade;J. Clin. Psychiatry,2017

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?;International Journal of Molecular Sciences;2024-01-29

2. Automated system for training and assessing reaching and grasping behaviors in rodents;Journal of Neuroscience Methods;2024-01

3. Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion;Brain Research;2023-12

4. Quinpirole inhibits levodopa-induced dyskinesias at structural and behavioral levels: Efficacy negated by co-administration of isradipine;Experimental Neurology;2023-11

5. Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation;Frontiers in Immunology;2023-10-04